SCHEMBL1241629

SCHEMBL1241629

CC(C)Cc1cccc(-c2ccccc2)c1[O]

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 1/20 0.47
GABRA1 P14867 1/20 0.46
GABRB2 P47870 1/20 0.46
PDCD1 Q15116 1/20 0.44
CD274 Q9NZQ7 1/20 0.44
DPP4 P27487 1/20 0.41
CDC25A P30304 1/20 0.39
CDC25B P30305 1/20 0.39
FOLH1 Q04609 1/20 0.38
MME P08473 1/20 0.38
ACE P12821 1/20 0.38
CPA1 P15085 1/20 0.38
ACE2 Q9BYF1 1/20 0.38
SLC6A2 P23975 1/20 0.38
SLC6A4 P31645 1/20 0.38
KCNA5 P22460 1/20 0.37
KCNH2 Q12809 1/20 0.37
ELANE P08246 1/20 0.37
CTSG P08311 1/20 0.37
PTGER1 P34995 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4630258 0.83 KMT2A (0.60) KMT2AGABRA1GABRB2PDCD1CD274
SCHEMBL3563149 0.81 PDCD1 (0.50) KMT2AGABRA1GABRB2PDCD1CD274
SCHEMBL4395702 0.80 GABRA1 (0.60) GABRA1GABRB2SLC6A2SLC6A4ELANE
SCHEMBL8679934 0.80 CD274 (0.65) KMT2AGABRA1GABRB2PDCD1CD274
Bicarbonate SCHEMBL27541289 0.80 KMT2A (0.68) KMT2AGABRA1GABRB2PDCD1CD274
SCHEMBL2416595 0.80 GABRA1 (0.47) KMT2AGABRA1GABRB2PDCD1CD274
SCHEMBL28428374 0.79 KMT2A (0.52) KMT2AGABRA1GABRB2PDCD1CD274
SCHEMBL3563200 0.76 PDCD1 (0.46) KMT2APDCD1CD274DPP4FOLH1
SCHEMBL4630088 0.75 KMT2A (0.40) KMT2APDCD1CD274CDC25ACDC25B
SCHEMBL8735456 0.75 GABRA1 (0.42) KMT2AGABRA1GABRB2PDCD1CD274

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2287162-B1 Derivatives of 4-piperazin-1-yl-4-benzo[b]thiophene suitable for the treatment of CNS disorders OTSUKA PHARMA CO LTD (JP) 2012-05-09 EP disclosed
EP-1919907-B9 HETEROCYCLIC COMPOUND OTSUKA PHARMA CO LTD (JP) 2012-01-18 EP disclosed
EP-1919907-B1 HETEROCYCLIC COMPOUND OTSUKA PHARMA CO LTD (JP) 2011-02-23 EP disclosed
EP-1919907-A2 HETEROCYCLIC COMPOUND OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2008-05-14 EP disclosed
WO-2007026959-A2 DERIVATIVES OF 4-PIPERAZIN-1-YL-4-BENZ0 [B] THIOPHENE SUITABLE FOR THE TREATMENT OF CNS DISORDERS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2007-03-08 WO disclosed